-
-
-
-
-
-
-
Crinetics CRNX) Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly
-
-
-
-
-
15,496 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

